Uptake of a Cervical Cancer Clinical Decision Support Tool: A Mixed-Methods Study

Author:

Huguet Nathalie1,Ezekiel-Herrera David1,Gunn Rose2,Pierce Alison2,O'Malley Jean2,Jones Matthew2,Marino Miguel1,Gold Rachel23

Affiliation:

1. Department of Family Medicine, Oregon Health and Science University, Portland, Oregon, United States

2. OCHIN Inc., Portland, Oregon, United States

3. Kaiser Permanente Northwest Center for Health Research, Portland, Oregon, United States

Abstract

Abstract Objectives Clinical decision support (CDS) tools that provide point-of-care reminders of patients' care needs may improve rates of guideline-concordant cervical cancer screening. However, uptake of such electronic health record (EHR)-based tools in primary care practices is often low. This study describes the frequency of factors associated with, and barriers and facilitators to adoption of a cervical cancer screening CDS tool (CC-tool) implemented in a network of community health centers. Methods This mixed-methods sequential explanatory study reports on CC-tool use among 480 community-based clinics, located across 18 states. Adoption of the CC-tool was measured as any instance of tool use (i.e., entry of cervical cancer screening results or follow-up plan) and as monthly tool use rates from November 1, 2018 (tool release date) to December 31, 2020. Adjusted odds and rates of tool use were evaluated using logistic and negative-binomial regression. Feedback from nine clinic staff representing six clinics during user-centered design sessions and semi-structured interviews with eight clinic staff from two additional clinics were conducted to assess barriers and facilitators to tool adoption. Results The CC-tool was used ≥1 time in 41% of study clinics during the analysis period. Clinics that ever used the tool and those with greater monthly tool use had, on average, more encounters, more patients from households at >138% federal poverty level, fewer pediatric encounters, higher up-to-date cervical cancer screening rates, and higher rates of abnormal cervical cancer screening results. Qualitative data indicated barriers to tool adoption, including lack of knowledge of the tool's existence, understanding of its functionalities, and training on its use. Conclusion Without effective systems for informing users about new EHR functions, new or updated EHR tools are unlikely to be widely adopted, reducing their potential to improve health care quality and outcomes.

Publisher

Georg Thieme Verlag KG

Subject

Health Information Management,Computer Science Applications,Health Informatics

Reference27 articles.

1. Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012;V B Benard;MMWR Morb Mortal Wkly Rep,2014

2. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement;V A Moyer;Ann Intern Med,2012

3. Trends over time in pap and Pap-HPV cotesting for cervical cancer screening;K L MacLaughlin;J Womens Health (Larchmt),2019

4. Prevalence of abnormal cervical cancer screening outcomes among screening-compliant women in the United States;O G Chido-Amajuoyi;Am J Obstet Gynecol,2019

5. Determinants of abnormal cervical cancer screening follow-up and invasive cervical cancer among uninsured and underinsured women in New Jersey;J Tsui;J Health Care Poor Underserved,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3